Effect of PARP inhibitors on sensitivity of lung and breast cancer cells to trans-platinum as compared to cis-platinum.

被引：0
|
作者：
Jankovic, Radmila [1 ]
Radulovic, Sinisa [1 ]
Arandjelovic, Sandra [1 ]
Filipovic, Lana [1 ]
机构：
[1] Inst Oncol & Radiol Serbia, Dept Expt Oncol, Belgrade, Serbia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e22115
引用
收藏
页数：1
相关论文
共 50 条
  • [41] NSCLC Mutated Isoforms of CCDC6 Affect the Intracellular Distribution of the Wild Type Protein Promoting Cisplatinum Resistance and PARP Inhibitors Sensitivity in Lung Cancer Cells
    Cerrato, Aniello
    Morra, Francesco
    Di Domenico, Imma
    Celetti, Angela
    CANCERS, 2020, 12 (01)
  • [42] Effect of Platinum-Based Chemotherapy on PD-L1 Expression on Tumor Cells in Non-small Cell Lung Cancer
    Shin, Junghoon
    Chung, Jin-Haeng
    Kim, Se Hyun
    Lee, Kyu Sang
    Suh, Koung Jin
    Lee, Ji Yun
    Kim, Ji-Won
    Lee, Jeong-Ok
    Kim, Jin-Won
    Kim, Yu-Jung
    Lee, Keun-Wook
    Kim, Jee Hyun
    Bang, Soo-Mee
    Lee, Jong-Seok
    CANCER RESEARCH AND TREATMENT, 2019, 51 (03): : 1086 - 1097
  • [43] Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer
    Ferrara, Roberto
    Imbimbo, Martina
    Malouf, Reem
    Paget-Bailly, Sophie
    Calais, Francois
    Marchal, Corynne
    Westeel, Virginie
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (04):
  • [44] Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer
    Ferrara, Roberto
    Imbimbo, Martina
    Malouf, Reem
    Paget-Bailly, Sophie
    Calais, Francois
    Marchal, Corynne
    Westeel, Virginie
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (12):
  • [45] Selective cytotoxicities of novel platinum(II) {[Pt(II)(trans-l/cis-DAPH)(PTP)]• 2NO3} on cancer cell-lines and normal kidney cells
    Jung, JC
    Park, SJ
    Chung, JH
    Chang, SG
    Park, JJ
    Lee, KT
    Rho, YS
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R530 - R530
  • [46] pH-Promoted Release of a Novel Anti-Tumour Peptide by “Stealth” Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells
    Francesca Sacchetti
    Gaetano Marverti
    Domenico D’Arca
    Leda Severi
    Eleonora Maretti
    Valentina Iannuccelli
    Salvatore Pacifico
    Glauco Ponterini
    Maria Paola Costi
    Eliana Leo
    Pharmaceutical Research, 2018, 35
  • [47] Modulation of Early Mitotic Inhibitor 1 (EMI1) depletion on the sensitivity of PARP inhibitors in BRCA1 mutated triple-negative breast cancer cells
    Moustafa, Dina
    Elwahed, Maha R. Abd
    Elsaid, Hanaa H.
    Parvin, Jeffrey D.
    PLOS ONE, 2021, 16 (01):
  • [48] pH-Promoted Release of a Novel Anti-Tumour Peptide by "Stealth" Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells
    Sacchetti, Francesca
    Marverti, Gaetano
    D'Arca, Domenico
    Severi, Leda
    Maretti, Eleonora
    Iannuccelli, Valentina
    Pacifico, Salvatore
    Ponterini, Glauco
    Costi, Maria Paola
    Leo, Eliana
    PHARMACEUTICAL RESEARCH, 2018, 35 (11)
  • [49] Cell death-inducing effect of novel palladium(II) and platinum(II) complexes on non-small cell lung cancer cells in vitro
    Ulukaya, Engin
    Ari, Ferda
    Dimas, Konstantinos
    Sarimahmut, Mehmet
    Guney, Emel
    Sakellaridis, Nikos
    Yilmaz, Veysel T.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (10) : 1425 - 1434
  • [50] Cell death-inducing effect of novel palladium(II) and platinum(II) complexes on non-small cell lung cancer cells in vitro
    Engin Ulukaya
    Ferda Ari
    Konstantinos Dimas
    Mehmet Sarimahmut
    Emel Guney
    Nikos Sakellaridis
    Veysel T. Yilmaz
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1425 - 1434
12345